Fas antigen (CD95) expression and apoptosis in hepatocytes of patients with chronic viral hepatitis

European Journal of Gastroenterology and Hepatology

Volumn 15, Issue 10, 2003, Pages 1079-1084

  Kiyici, Murat ^a   Gurel, Selim ^a   Budak, Ferah ^a   Dolar, Enver ^a   Gulten, Macit ^a   Nak, Selim Giray ^a   Memik, Faruk ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Apoptosis; Chronic viral hepatitis; Fas antigen

Indexed keywords

AMINOTRANSFERASE; FAS ANTIGEN;

ADOLESCENT; ADULT; AGE; AMINOTRANSFERASE BLOOD LEVEL; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ASSAY; FEMALE; FLOW CYTOMETRY; HEPATITIS B VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS HEPATITIS;

ADOLESCENT; ADULT; ANTIGENS, CD95; APOPTOSIS; DNA FRAGMENTATION; FEMALE; FLOW CYTOMETRY; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HEPATOCYTES; HUMANS; MALE; MIDDLE AGED; TRANSAMINASES;

EID: 0142107398     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200310000-00003     Document Type: Article

References (26)

1. Schiff ER. Viral hepatitis. In: Schiff ER, Sorrell MF, Maddrey WC (editors). Schiff's Diseases of the Liver, vol. 1, 8th edition. Philadelphia: Lippincott Williams & Wilkins; 1999, pp. 719-724.
2. Arends MJ, Wyllie AH. Apoptosis: mechanisms and roles in pathology. Int Rev Exp Pathol 1991; 32:223-254.
3. Wyllie AH, Duval E. Cell injury and death. In: McGee JOD, Isaacson PG, Wright NA (editors). Oxford Textbook of Pathology. Oxford: Oxford University Press; 1992, pp. 141-157.
4. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267:1456-1462.
5. Que FG, Gores G. Cell death by apoptosis: basic concepts and disease relevance for the gastroenterologist. Gastroenterology 1996; 110: 1238-1243.
6. Patel TC, Gores GJ. Apoptosis and hepatobiliary disease. Hepatology 1995; 21:1725-1741.
7. Nagata S. Fas and Fas ligand: a death factor and its receptor. Adv Immunol 1994; 57:129-144.
8. Nagata S, Goldstein P. The Fas death factor. Science 1995; 267: 1449-1456.
9. Smith CA, Farrah T, Goodwin RG. The TNF receptor superfamily of cellular and viral proteins: activation, co-stimulation, and death. Cell 1994; 76:959-962.
10. Knodell RG, Ishac KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1:431-435.
11. Feray C, Brenot C, Di Martino V, et al. Liver HCV RNA is correlated to Fas mRNA and to apoptosis in liver transplanted patients infected by hepatitis C. J Hepatol 1998; 28 (suppl 1):97.
12. Nakamura K, Yuh K, Sugyo S, Shijo H, Kimura N, Okumura M. Apoptosis observed in peripheral T lymphocytes from patients with chronic hepatitis B. Gastroenterology 1996; 111:156-164.
13. Farinati F, Cardin R, D'Errico A, et al. Apoptosis and cytoproliferation in chronic HCV-related hepatitis. J Hepatol 1998; 28 (suppl 1):177.
14. Lawrence JD, Dean PJ. Mechanisms of chemically induced liver disease. In: Zakim D, Boyer TD (editors). Hepatology: a Textbook of Liver Disease, 3rd edition. Philadelphia: W.B. Saunders Company; 1996, pp. 875-888.
15. Ando K, Hiroishi K, Kaneko T, Moriyama T, Muto Y, Kayagaki N, et al. Perforin, Fas /Fas ligand, and TNF-α pathways as specific and bystander killing mechanism of hepatitis C virus-specific human CTL. J Immunol 1997; 158:5283-5291.
16. Hamazaki K, Gochi A, Matsubara N, Mori M, Orita K. Expression of Fas antigen and Bcl-2 protein in hepatocellular carcinoma. Acta Med Okayama 1995; 49:227-230.
17. Higaki K, Yano H, Kojiro M. Fas antigen expression and its relationship with apoptosis in human hepatocellular carcinoma and non-cancerous tissues. Am J Pathol 1996; 149:429-437.
18. Gressner AM, Lahme B, Mannherz HG, Polzar B. TGF-β-mediated hepatocellular apoptosis by rat and human hepatoma cells and primary rat hepatocytes. J Hepatol 1997; 26:1079-1092.
19. Galle PR, Hofmann WJ, Walczak H, Schaller H, Otto G, Stremmel W, et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med 1995; 182:1223-1230.
20. Hiramatsu N, Hayashi N, Katayama K, Mochizuki K, Kawanishi Y, Kasahara A, et al. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology 1994; 19: 1354-1359.
21. Mochizuki K, Hayashi N, Hiramatsu N, Katayama K, Kawanishi Y, Kasahara A, et al. Fas antigen expression in liver tissues of patients with chronic hepatitis B. J Hepatol 1996; 24:1-7.
22. Leithauser F, Dhein J, Mechtersheimer G, Koretz K, Bruderlein S, Henne C, et al. Constitutive and induced expression of Apo-1: a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab Invest 1993; 69:415-429.
23. Tsugeno H, Yamada G, Takatani M, et al. Immunohistochemical study of Fas antigen in human liver tissues. Hepatology 1994; 202:145A.
24. 2+-independent T cell-mediated cytotoxicity. J Exp Med 1993; 177:195-200.
25. Seino KI, Kayagaki N, Takeda K, Fukao K, Okumura K, Yagita H. Contribution of Fas ligand to T cell-mediated hepatic injury in mice. Gastroenterology 1997; 113:1315-1322.
26. Tenniswood MP, Guenette RS, Lakins J, Mooibroek L, Wong P, Welsh J-E. Active cell death in hormone-dependent tissues. Cancer Metastasis Rev 1992; 11:197-220.